retatrutide latest news Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide Achieves Large Weight Decreases

Metabolic rate typically remains stable or increases on GLP-1 therapy, even with intermittent fasting, as long as you avoid chronic undereating

During the first weeks or months, some people unintentionally under-eat as their body adjusts

A plateau usually means weight loss has slowed or paused before the patient has a clear long-term plan

We summarised the current evidence and available recommendations from the ASA and ESAIC to support clinicians in the perioperative management of patients receiving SGLT2 inhibitors, GLP-1RAs and related therapies (Table 2)

Methods We conducted a systematic review and meta-analysis of randomised controlled trials (RCTs) comparing any GLP-1RA with placebo or active comparators reporting validated measures of binge eating, disinhibited eating, and loss of control eating

There are options available, including services like collaboratingdocs.com